RVMD – Revolution Medicines, Inc.
Revolution Medicines, Inc.RVMD
$36.63Name : Revolution Medicines, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $6,822,996,992.00
EPSttm : -4.01
Revolution Medicines, Inc.
$36.63
1.72%$0.64Float Short %
8.44
Margin Of Safety %
Put/Call OI Ratio
0.57
EPS Next Q Diff
-0.05
EPS Last/This Y
-1.11
EPS This/Next Y
-0.41
Price
36.63
Target Price
72.25
Analyst Recom
1.08
Performance Q
-9.87
Relative Volume
0.44
Beta
1.16
Ticker: RVMD
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | RVMD | 37.99 | 0.76 | 0.56 | 23529 |
| 2025-07-07 | RVMD | 36.7 | 0.75 | 1.49 | 23711 |
| 2025-07-08 | RVMD | 36.44 | 0.75 | 5.68 | 23879 |
| 2025-07-09 | RVMD | 38.54 | 0.76 | 10.28 | 23970 |
| 2025-07-10 | RVMD | 38.51 | 0.76 | 6.29 | 24096 |
| 2025-07-11 | RVMD | 38.02 | 0.77 | 4.37 | 24155 |
| 2025-07-14 | RVMD | 38.38 | 0.77 | 1.17 | 24244 |
| 2025-07-15 | RVMD | 37.8 | 0.77 | 1.23 | 24316 |
| 2025-07-16 | RVMD | 38.41 | 0.77 | 1.70 | 24766 |
| 2025-07-17 | RVMD | 39.04 | 0.77 | 0.94 | 24930 |
| 2025-07-18 | RVMD | 38.29 | 0.77 | 1.62 | 25048 |
| 2025-07-21 | RVMD | 38.42 | 2.23 | 2.01 | 13642 |
| 2025-07-22 | RVMD | 38.28 | 2.21 | 3.01 | 13811 |
| 2025-07-23 | RVMD | 37.53 | 2.19 | 4.87 | 14050 |
| 2025-07-24 | RVMD | 37.19 | 2.18 | 1.75 | 14106 |
| 2025-07-25 | RVMD | 37.92 | 2.13 | 0.01 | 14113 |
| 2025-07-28 | RVMD | 37.28 | 0.66 | 0.66 | 24161 |
| 2025-07-29 | RVMD | 36.99 | 0.66 | 0.25 | 24201 |
| 2025-07-30 | RVMD | 37.01 | 0.65 | 0.66 | 24363 |
| 2025-07-31 | RVMD | 37.26 | 0.65 | 0.15 | 24396 |
| 2025-08-01 | RVMD | 36.62 | 0.57 | 0.86 | 26626 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | RVMD | 37.87 | -38.4 | -222.9 | -4.68 |
| 2025-07-07 | RVMD | 36.70 | -38.4 | -155.5 | -4.68 |
| 2025-07-08 | RVMD | 36.44 | -38.4 | -189.2 | -4.68 |
| 2025-07-09 | RVMD | 38.52 | -38.4 | -277.3 | -4.68 |
| 2025-07-10 | RVMD | 38.50 | -38.4 | -197.3 | -4.68 |
| 2025-07-11 | RVMD | 38.02 | -38.4 | -180.3 | -4.68 |
| 2025-07-14 | RVMD | 38.37 | -38.4 | -210.4 | -4.68 |
| 2025-07-15 | RVMD | 37.81 | -38.4 | -178.1 | -4.68 |
| 2025-07-16 | RVMD | 38.39 | -38.4 | -218.9 | -4.68 |
| 2025-07-17 | RVMD | 39.05 | -38.4 | -220.9 | -4.68 |
| 2025-07-18 | RVMD | 38.31 | -38.4 | -172.2 | -4.68 |
| 2025-07-21 | RVMD | 38.41 | -38.4 | -201.9 | -4.68 |
| 2025-07-22 | RVMD | 38.26 | -38.4 | -192.3 | -4.68 |
| 2025-07-23 | RVMD | 37.53 | -38.4 | -171.6 | -4.68 |
| 2025-07-24 | RVMD | 37.22 | -38.5 | -186.5 | -4.69 |
| 2025-07-25 | RVMD | 37.90 | -38.5 | -223.2 | -4.69 |
| 2025-07-28 | RVMD | 37.33 | -38.5 | -177.0 | -4.69 |
| 2025-07-29 | RVMD | 37.01 | -38.5 | -188.7 | -4.69 |
| 2025-07-30 | RVMD | 37.01 | -38.5 | -198.1 | -4.69 |
| 2025-07-31 | RVMD | 37.27 | -38.5 | -207.4 | -4.69 |
| 2025-08-01 | RVMD | 36.63 | -38.5 | -174.3 | -4.69 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | RVMD | -0.23 | -0.50 | 11.22 |
| 2025-07-07 | RVMD | -0.23 | -0.52 | 11.22 |
| 2025-07-08 | RVMD | -0.23 | -0.52 | 11.22 |
| 2025-07-09 | RVMD | -0.23 | -0.52 | 11.22 |
| 2025-07-10 | RVMD | -0.23 | -0.52 | 11.22 |
| 2025-07-11 | RVMD | -0.23 | -0.52 | 9.95 |
| 2025-07-14 | RVMD | -0.23 | -0.44 | 9.95 |
| 2025-07-15 | RVMD | -0.23 | -0.44 | 9.95 |
| 2025-07-16 | RVMD | -0.23 | -0.44 | 9.95 |
| 2025-07-17 | RVMD | -0.23 | -0.44 | 9.95 |
| 2025-07-18 | RVMD | -0.23 | -0.44 | 9.95 |
| 2025-07-21 | RVMD | -0.23 | -0.38 | 9.95 |
| 2025-07-22 | RVMD | -0.23 | -0.38 | 9.95 |
| 2025-07-23 | RVMD | -0.22 | -0.38 | 9.95 |
| 2025-07-24 | RVMD | -0.22 | -0.38 | 9.95 |
| 2025-07-25 | RVMD | -0.22 | -0.38 | 8.44 |
| 2025-07-28 | RVMD | -0.22 | -5.20 | 8.44 |
| 2025-07-29 | RVMD | -0.22 | -5.20 | 8.44 |
| 2025-07-30 | RVMD | -0.22 | -5.20 | 8.44 |
| 2025-07-31 | RVMD | -0.22 | -5.20 | 8.44 |
| 2025-08-01 | RVMD | -0.22 | -5.20 | 8.44 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.13
Avg. EPS Est. Current Quarter
-1.14
Avg. EPS Est. Next Quarter
-1.18
Insider Transactions
-0.22
Institutional Transactions
-5.2
Beta
1.16
Average Sales Estimate Current Quarter
28
Average Sales Estimate Next Quarter
27
Fair Value
Quality Score
8
Growth Score
17
Sentiment Score
14
Actual DrawDown %
41.3
Max Drawdown 5-Year %
-73.3
Target Price
72.25
P/E
Forward P/E
PEG
P/S
P/B
3.28
P/Free Cash Flow
EPS
-4
Average EPS Est. Cur. Y
-4.69
EPS Next Y. (Est.)
-5.1
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.44
Return on Equity vs Sector %
-57.3
Return on Equity vs Industry %
-38.7
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.04
EBIT Estimation
-174.3
Revolution Medicines, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 616
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading